Adrenomedullin (AM) (1-52), human
(Synonyms: Human adrenomedullin-(1-52)-NH2) 目录号 : GC33955
Adrenomedullin (AM) (1-52), human是一种由52个氨基酸组成的生物活性多肽,属于降钙素基因相关肽超家族,具有显著的血管舒张作用。
Cas No.:148498-78-6
Sample solution is provided at 25 µL, 10mM.
Adrenomedullin (AM) (1-52), human is a biologically active peptide composed of 52 amino acids, belonging to the calcitonin gene-related peptide superfamily, and exhibits significant vasodilatory effects[1-2]. Adrenomedullin (AM) (1-52), human acts as a regulatory factor for the growth of adult neural stem cells, influencing their proliferation rate and differentiation fate into neurons, astrocytes, and oligodendrocytes[3]. Adrenomedullin (AM) (1-52), human can modulate the proliferation process of cancer cells and promote angiogenesis, playing an important role in both cancer development and vascular formation during tissue repair[4].
In vitro, pretreatment of H9c2 cardiomyocytes with Adrenomedullin (AM) (1-52), human (10nM) for 30 minutes, followed by stimulation with palmitic acid (200μM) for 24 hours, significantly suppressed the protein expression of pro-inflammatory cytokines TNF-α, IL-1β, and IL-6, while reducing intracellular reactive oxygen species levels and improving cell viability[5]. In hypoxically cultured bovine articular chondrocytes, pretreatment with Adrenomedullin (AM) (1-52), human (100nM) for 30 minutes, followed by stimulation with Fas ligand (20ng/mL) for 24 hours, significantly inhibited the activity of caspase-3 and caspase-8, while reducing the apoptosis rate[6].
In vivo, continuous infusion of Adrenomedullin (AM) (1-52), human (0.05mg/kg/h) via a carotid artery catheter in a C57/BL6 mouse model of lung injury induced by high tidal volume (17ml/kg) mechanical ventilation for 2 hours or moderate tidal volume (12ml/kg) ventilation for 6 hours, significantly reduced ventilator-induced increases in pulmonary vascular permeability and improved oxygenation function[7]. Continuous subcutaneous infusion of Adrenomedullin (AM) (1-52), human (0.05mg/kg/min) via an osmotic minipump in BALB/c mice treated with a single intraperitoneal injection of doxorubicin (20mg/kg) significantly improved the 14-day survival rate of mice exposed to high-dose doxorubicin and reduced serum lactate dehydrogenase levels[8].
References:
[1] Martínez-Herrero S, Martínez A. Adrenomedullin: Not Just Another Gastrointestinal Peptide. Biomolecules. 2022 Jan 18;12(2):156.
[2] Ferrero H, Larrayoz IM, Gil-Bea FJ, et al. Adrenomedullin, a Novel Target for Neurodegenerative Diseases. Mol Neurobiol. 2018 Dec;55(12):8799-8814.
[3] Nishikimi T, Kinoshita H, Inazumi H, et al. Adrenomedullin in pulmonary hypertension. Dan Med J. 2024 Nov 15;71(12):A07240498.
[4] Li H, Yang W, Wang S, et al. Adrenomedullin in Tumorigenesis and Cancer Progression. Int J Mol Sci. 2025 Jun 10;26(12):5552.
[5] Qian P, Wang Q, Wang FZ, et al. Adrenomedullin Improves Cardiac Remodeling and Function in Obese Rats with Hypertension. Pharmaceuticals (Basel). 2022 Jun 6;15(6):719.
[6] Velard F, Chatron-Colliet A, Côme D, et al. Adrenomedullin and truncated peptide adrenomedullin(22-52) affect chondrocyte response to apoptotis in vitro: downregulation of FAS protects chondrocyte from cell death. Sci Rep. 2020 Oct 7;10(1):16740.
[7] Müller HC, Witzenrath M, Tschernig T, et al. Adrenomedullin attenuates ventilator-induced lung injury in mice. Thorax. 2010 Dec;65(12):1077-84.
[8] Yoshizawa T, Takizawa S, Shimada S, et al. Effects of Adrenomedullin on Doxorubicin-Induced Cardiac Damage in Mice. Biol Pharm Bull. 2016 May 1;39(5):737-46.
Adrenomedullin (AM) (1-52), human是一种由52个氨基酸组成的生物活性多肽,属于降钙素基因相关肽超家族,具有显著的血管舒张作用[1-2]。Adrenomedullin (AM) (1-52), human能作为成年神经干细胞生长的调节因子,影响其增殖速率以及向神经元、星形胶质细胞和少突胶质细胞的分化命运[3]。Adrenomedullin (AM) (1-52), human能够影响癌细胞的增殖过程并促进血管生成,在癌症发展和组织修复的血管形成中扮演重要角色[4]。
在体外,Adrenomedullin (AM) (1-52), human (10nM) 预处理H9c2心肌细胞30分钟,随后以棕榈酸 (200μM) 刺激24小时,Adrenomedullin (AM) (1-52), human显著抑制促炎因子TNF-α、IL-1β和IL-6的蛋白表达,同时降低细胞内活性氧水平并改善细胞活力[5]。Adrenomedullin (AM) (1-52), human(100nM)预处理缺氧培养的牛关节软骨细胞30分钟,随后以Fas配体(20ng/mL)刺激24小时,Adrenomedullin (AM) (1-52), human显著抑制caspase-3和caspase-8的活性,同时降低细胞凋亡率[6]。
在体内,Adrenomedullin (AM) (1-52), human (0.05mg/kg/h) 通过颈动脉导管持续输注,用于处理接受高潮气量(17ml/kg)机械通气2小时或中等潮气量(12ml/kg)通气6小时诱导的肺损伤C57/BL6小模型,Adrenomedullin (AM) (1-52), human显著降低了呼吸机诱导的肺血管通透性增高,同时改善了氧合功能[7]。Adrenomedullin (AM) (1-52), human (0.05mg/kg/min) 通过渗透性微型泵持续皮下输注,用于处理单次腹腔注射20mg/kg阿霉素的BALB/c小鼠,Adrenomedullin (AM) (1-52), human显著提高了高剂量阿霉素处理小鼠的14天生存率,同时降低了血清乳酸脱氢酶水平[8]。
| Cell experiment [1]: | |
Cell lines | H9c2 cardiomyocytes (rat embryonic heart-derived cell line) |
Preparation Method | H9c2 cells were maintained in DMEM/F12 medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin at 37°C, 5% CO₂. Cells were pretreated with Adrenomedullin (AM) (1-52), human (10nM) for 30min, followed by exposure to palmitic acid (PA; 200μM) for 24h to mimic lipotoxicity. |
Reaction Conditions | 10nM; pretreatment for 30min |
Applications | Adrenomedullin (AM) (1-52), human significantly attenuated PA-induced cytotoxicity and improved cell viability. Adrenomedullin (AM) (1-52), human reduced PA-triggered reactive oxygen species (ROS) production and NADPH oxidase activity, while restoring the expression of antioxidant enzymes (GPx1, SOD2, CAT). Adrenomedullin (AM) (1-52), human also suppressed PA-induced pro-inflammatory cytokine levels (TNF-α, IL-1β, IL-6) and enhanced Akt phosphorylation. |
| Animal experiment [2]: | |
Animal models | BALB/c mice |
Preparation Method | Mice received a single intraperitoneal injection of Doxorubicin (DOX; 20mg/kg for survival analysis). Adrenomedullin (AM) (1-52), human was administered via continuous subcutaneous infusion using an osmotic minipump at a rate of 0.05mg/kg/min for 3, 7, or 14 days. Cardiac tissue and serum samples were collected at designated time points. |
Dosage form | 0.05mg/kg/min; continuous subcutaneous infusion. |
Applications | Adrenomedullin (AM) (1-52), human significantly improved the survival rate of mice treated with high-dose DOX, increasing 14-day survival from 9.52% to 30%. Adrenomedullin (AM) (1-52), human attenuated DOX-induced cardiac damage, as evidenced by reduced serum lactate dehydrogenase (LDH) and creatine kinase (CK) levels on days 7 and 14. |
References: | |
| Cas No. | 148498-78-6 | SDF | |
| 别名 | Human adrenomedullin-(1-52)-NH2 | ||
| Canonical SMILES | Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 (Disulfide bridge: Cys16-Cys21) | ||
| 分子式 | C264H406N80O77S3 | 分子量 | 6028.82 |
| 溶解度 | Soluble in Water | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 165.9 μL | 829.3 μL | 1.6587 mL |
| 5 mM | 33.2 μL | 165.9 μL | 331.7 μL |
| 10 mM | 16.6 μL | 82.9 μL | 165.9 μL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















